Article

Tumor-associated antigen peptides as anti-metastatic vaccines

Letters in Peptide Science 04/1998; 5(5):323-328. DOI:10.1007/BF02443479 pp.323-328

ABSTRACT Cytotoxic T-lymphocytes (CTLs) kill abnormal cells. CTLs recognize major histocompatibility complex class I molecules in complex
with peptides derived from relevant antigens. The identification of tumor associated antigen peptides enabled the design of
anti-tumor and anti-metastatic vaccines in a murine lung carcinoma.

0 0
 · 
0 Bookmarks
 · 
25 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

anti-tumor
 
Cytotoxic T-lymphocytes
 
major histocompatibility complex class
 
murine lung carcinoma